Author’s response to reviews Title: A Novel Combined Systemic Inflammation-Based Score Can Predict Survival of Intermediate-to-Advanced Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization
نویسندگان
چکیده
Title: A Novel Combined Systemic Inflammation-Based Score Can Predict Survival of Intermediate-to-Advanced Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization Authors: Chang Liu ([email protected]) Lei Li ([email protected]) Wu-sheng Lu ([email protected]) Hua Du ([email protected]) Lu-nan Yan ([email protected]) Jia-yin Yang ([email protected]) Tian-fu Wen ([email protected]) Wu-ran Wei ([email protected]) Li Jiang ([email protected]) Wen-tao Wang ([email protected]) Ming-qing Xu ([email protected]) Version: 1 Date: 04 Aug 2017 Author’s response to reviews: Dear Editor, I have reviesed the maunuscript according to the guide. I am sorry for bringing trouble with you. Thanks for your work.
منابع مشابه
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101
BACKGROUND The systemic inflammatory response plays an important role in cancer development and progression. An original inflammation-based staging system for predicting survival in patients undergoing transarterial chemoembolization (TACE) combined with recombinant human type-5 adenovirus H101 is not available. This study aimed to validate the prognostic value of inflammation scores for patien...
متن کاملFactors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
♦Corresponding Author: Muhammed Mubarak, MD Histopathology Department, Sindh Institute of Urology and Transplantation, Karachi-74200, Pakistan Tel: +9221 99215752 Fax: +9221 32726165 Email: [email protected] Abstract Background: Transarterial chemoembolization is the preferred treatment for unresectable, intermediate-stage hepatocellular carcinoma. Survival after transarterial chemoemboli...
متن کاملCombined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study
BACKGROUND The prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is variable, despite a myriad of prognostic markers. We compared and integrated the established prognostic models, HAP and ART scores, for their accuracy of overall survival (OS) prediction. RESULTS In both training and validation sets, HAP and ART scores emerged as indep...
متن کاملTransarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study
BACKGROUND Patients with intermediate to advanced hepatocellular carcinoma (HCC) are most commonly treated with transarterial chemoembolization (TACE). Previous studies showed that TACE combined with recombinant human adenovirus type 5 (H101) may provide a clinical survival benefit. In the present study, we aimed to determine the survival benefit of TACE with or without H101 for patients with i...
متن کاملConventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
Transarterial chemoembolization (TACE) is the current standard of therapy for patients with intermediate-stage hepatocellular carcinoma (HCC) according to the Barcelona Clinic Liver Cancer classification. The concept of conventional TACE (cTACE) is the selective obstruction of tumor-feeding artery by injection of chemotherapeutic agents, leading to ischemic necrosis of the target tumor via cyto...
متن کامل